From our analysis, only a minority of genes complied with the criteria: 69 and 10 genes in BRCA1 and BRCA2 mutated breast cancers, respectively, and 10 and 9 genes in BRCA1 and BRCA2 mutated ovarian cancers, respectively. This evidence concerns the gene BRCA2 and breast carcinoma.